Entering text into the input field will update the search result below

PBIGF Paradigm Biopharmaceuticals Limited
Stock Price & Overview

$0.460.05 (+13.05%)10:50 AM 09/12/23
Pink Current Info | $USD | Market Close


Div Rate (TTM)
Yield (TTM)
Short Interest
Market Cap
Prev. Close

Quant Ranking

Company Profile

Paradigm Biopharmaceuticals Limited logo
Paradigm Biopharmaceuticals Limited engages in the research and development of therapeutic products for human use in Australia. It offers pentosan polysulfate sodium drugs in the injectable form for the treatment of osteoarthritis, mucopolysaccharidosis, ross river virus, chikungunya virus, chronic heart failure, allergic respiratory, and acute respiratory distress syndrome diseases. The company was incorporated in 2014 and is based in Melbourne, Australia.
  • 500 Collins Street
  • Level 15
  • Melbourne, VIC, 3000
  • Australia
Phone Number
61 3 9629 5566
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.